LIXTE Biotechnology (LIXT) announced that Lourdes Felix and Guy Primus have joined the Company’s Board of Directors, and Peter Stazzone has been named Chief Financial Officer. The Company also announced that it has relocated its corporate headquarters to Boca Raton. The new board members succeed Bas van der Baan, who remains Chief Scientific Officer of LIXTE, and Rene Bernards, PhD, who has been named Chairman of LIXTE’s Scientific Advisory Board. Stazzone succeeds Robert Weingarten, who has left the Company to pursue other interests.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIXT:
- Lixte Biotechnology Raises $6.5M, Appoints New Management
- Lixte Biotechnology provides update on recent corporate activities
- Lixte Biotechnology Adopts Cryptocurrency in Treasury Policy
- Lixte Biotechnology updates treasury policy to include cryptocurrency
- Lixte Biotechnology Regains Nasdaq Compliance After Fundraising